← FDA DRUG APPROVALS

FDA ANDA · ANDA090143

DORZOLAMIDE HCL

Sponsor: BAUSCH AND LOMB

APPLICATION
ANDA090143
TYPE
ANDA
ORIGINAL APPROVAL
2009-06-25
LATEST ACTION
2013-02-20
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription

Products

DORZOLAMIDE HYDROCHLORIDEPrescription
DORZOLAMIDE HYDROCHLORIDE EQ 2% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2013-02-20Labeling · Supplement 5 · standardAP
2009-06-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →